Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo

Identifieur interne : 002731 ( Main/Exploration ); précédent : 002730; suivant : 002732

Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo

Auteurs : Mark D. Tolpin [États-Unis] ; Judith G. Massicot [États-Unis] ; Mary G. Mullinix [États-Unis] ; Hyun Wha Kim [États-Unis] ; Robert H. Parrott [États-Unis] ; Robert M. Chanock [États-Unis] ; Brian R. Murphy [États-Unis]

Source :

RBID : ISTEX:F8B30400DE92CE68D6CB321902227B108E7C2901

English descriptors

Abstract

Abstract: The influenza A/Alaska/77-ts-1A2 vaccine candidate strain, which has a 37° shutoff temperature for plaque formation and temperature-sensitive (ts) lesions on the P1 and P3 genes, was administered intranasally to a seronegative child who subsequently remained well. However, starting 7 days after inoculation, A/Alaska/77 virus with a 40° shutoff temperature (ts+) was shed. To determine whether an extragenic suppressor mutation was responsible for this loss of ts phenotype of the vaccine candidate virus, the ts+ isolate was mated with wild-type virus, and ts recombinant progeny were sought. Approximately 25% of the progeny were ts, suggesting that a suppressor mutation was present in the child's ts+ isolate. Each of 62 ts progeny viruses had the ts P3 gene. The extragenic suppressor of this ts gene was localized to the P2 gene. The ts P3 gene of the A/Alaska/77-ts-1A2 recombinant specified a 37–38° shutoff temperature for plaque formation, whereas the ts P3 gene in the ts segregants derived from the ts+ isolate had a 39° shutoff temperature. Hence, the ts P3 gene in the ts+ isolate developed an intragenic mutation affecting its level of temperature sensitivity. In addition, the P3 RNA of the ts+ virus migrated more slowly in polyacrylamide gel than the P3 RNA of its A/Alaska/77-ts-1A2 parent. We failed to isolate ts P1 segregants from the ts+ isolate, indicating that the P1 ts mutation had reverted or undergone intragenic suppression. The ability of ts mutants to escape from their ts phenotype by suppression and other mutations may limit their usefulness in immunoprophylaxis since attenuation of ts mutants of influenza virus appears to be a function of the ts phenotype. Additionally, suppressor mutations provide new opportunities for studying the nature of protein-protein interactions.

Url:
DOI: 10.1016/0042-6822(81)90298-1


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo</title>
<author>
<name sortKey="Tolpin, Mark D" sort="Tolpin, Mark D" uniqKey="Tolpin M" first="Mark D." last="Tolpin">Mark D. Tolpin</name>
</author>
<author>
<name sortKey="Massicot, Judith G" sort="Massicot, Judith G" uniqKey="Massicot J" first="Judith G." last="Massicot">Judith G. Massicot</name>
</author>
<author>
<name sortKey="Mullinix, Mary G" sort="Mullinix, Mary G" uniqKey="Mullinix M" first="Mary G." last="Mullinix">Mary G. Mullinix</name>
</author>
<author>
<name sortKey="Kim, Hyun Wha" sort="Kim, Hyun Wha" uniqKey="Kim H" first="Hyun Wha" last="Kim">Hyun Wha Kim</name>
</author>
<author>
<name sortKey="Parrott, Robert H" sort="Parrott, Robert H" uniqKey="Parrott R" first="Robert H." last="Parrott">Robert H. Parrott</name>
</author>
<author>
<name sortKey="Chanock, Robert M" sort="Chanock, Robert M" uniqKey="Chanock R" first="Robert M." last="Chanock">Robert M. Chanock</name>
</author>
<author>
<name sortKey="Murphy, Brian R" sort="Murphy, Brian R" uniqKey="Murphy B" first="Brian R." last="Murphy">Brian R. Murphy</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F8B30400DE92CE68D6CB321902227B108E7C2901</idno>
<date when="1981" year="1981">1981</date>
<idno type="doi">10.1016/0042-6822(81)90298-1</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-LXZ1ZGSM-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001784</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001784</idno>
<idno type="wicri:Area/Istex/Curation">001784</idno>
<idno type="wicri:Area/Istex/Checkpoint">001363</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001363</idno>
<idno type="wicri:doubleKey">0042-6822:1981:Tolpin M:genetic:factors:associated</idno>
<idno type="wicri:Area/Main/Merge">002876</idno>
<idno type="wicri:Area/Main/Curation">002731</idno>
<idno type="wicri:Area/Main/Exploration">002731</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo</title>
<author>
<name sortKey="Tolpin, Mark D" sort="Tolpin, Mark D" uniqKey="Tolpin M" first="Mark D." last="Tolpin">Mark D. Tolpin</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205</wicri:regionArea>
<wicri:noRegion>Maryland 20205</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Massicot, Judith G" sort="Massicot, Judith G" uniqKey="Massicot J" first="Judith G." last="Massicot">Judith G. Massicot</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205</wicri:regionArea>
<wicri:noRegion>Maryland 20205</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mullinix, Mary G" sort="Mullinix, Mary G" uniqKey="Mullinix M" first="Mary G." last="Mullinix">Mary G. Mullinix</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205</wicri:regionArea>
<wicri:noRegion>Maryland 20205</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Hyun Wha" sort="Kim, Hyun Wha" uniqKey="Kim H" first="Hyun Wha" last="Kim">Hyun Wha Kim</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Children's Hospital National Medical Center, Washington, D.C. 20010</wicri:regionArea>
<wicri:noRegion>D.C. 20010</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Parrott, Robert H" sort="Parrott, Robert H" uniqKey="Parrott R" first="Robert H." last="Parrott">Robert H. Parrott</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Children's Hospital National Medical Center, Washington, D.C. 20010</wicri:regionArea>
<wicri:noRegion>D.C. 20010</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chanock, Robert M" sort="Chanock, Robert M" uniqKey="Chanock R" first="Robert M." last="Chanock">Robert M. Chanock</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205</wicri:regionArea>
<wicri:noRegion>Maryland 20205</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murphy, Brian R" sort="Murphy, Brian R" uniqKey="Murphy B" first="Brian R." last="Murphy">Brian R. Murphy</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205</wicri:regionArea>
<wicri:noRegion>Maryland 20205</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Virology</title>
<title level="j" type="abbrev">YVIRO</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1981">1981</date>
<biblScope unit="volume">112</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="505">505</biblScope>
<biblScope unit="page" to="517">517</biblScope>
</imprint>
<idno type="ISSN">0042-6822</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0042-6822</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Attenuation</term>
<term>Biological characterization</term>
<term>Chanock</term>
<term>Clone</term>
<term>Donor virus</term>
<term>Extragenic</term>
<term>Extragenic suppression</term>
<term>Extragenic suppressor</term>
<term>Extragenic suppressor mutations</term>
<term>Gene</term>
<term>Genetic instability</term>
<term>Greater reduction</term>
<term>Influenza</term>
<term>Influenza virus</term>
<term>Intragenic</term>
<term>Intragenic suppression</term>
<term>Lesion</term>
<term>Levine</term>
<term>Massicot</term>
<term>Mutant</term>
<term>Mutation</term>
<term>Palese</term>
<term>Parental origin</term>
<term>Phenotype</term>
<term>Plaque</term>
<term>Plaque formation</term>
<term>Progeny</term>
<term>Recombinant</term>
<term>Recombinant virus</term>
<term>Recombinant viruses</term>
<term>Reovirus</term>
<term>Reovirus type</term>
<term>Richman</term>
<term>Segregants</term>
<term>Seronegative</term>
<term>Seronegative child</term>
<term>Shutoff</term>
<term>Shutoff temperature</term>
<term>Suppressor</term>
<term>Suppressor mutation</term>
<term>Surface antigens</term>
<term>Temperature sensitivity</term>
<term>Temperaturesensitive mutants</term>
<term>Tolpin</term>
<term>Unpublished observation</term>
<term>Unpublished observations</term>
<term>Vaccine</term>
<term>Vaccinee</term>
<term>Virion</term>
<term>Virion rnas</term>
<term>Virology</term>
<term>Virus</term>
<term>Virus evaluation</term>
<term>Virus titer</term>
<term>Wild type</term>
<term>Wildtype</term>
<term>Wildtype virus</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The influenza A/Alaska/77-ts-1A2 vaccine candidate strain, which has a 37° shutoff temperature for plaque formation and temperature-sensitive (ts) lesions on the P1 and P3 genes, was administered intranasally to a seronegative child who subsequently remained well. However, starting 7 days after inoculation, A/Alaska/77 virus with a 40° shutoff temperature (ts+) was shed. To determine whether an extragenic suppressor mutation was responsible for this loss of ts phenotype of the vaccine candidate virus, the ts+ isolate was mated with wild-type virus, and ts recombinant progeny were sought. Approximately 25% of the progeny were ts, suggesting that a suppressor mutation was present in the child's ts+ isolate. Each of 62 ts progeny viruses had the ts P3 gene. The extragenic suppressor of this ts gene was localized to the P2 gene. The ts P3 gene of the A/Alaska/77-ts-1A2 recombinant specified a 37–38° shutoff temperature for plaque formation, whereas the ts P3 gene in the ts segregants derived from the ts+ isolate had a 39° shutoff temperature. Hence, the ts P3 gene in the ts+ isolate developed an intragenic mutation affecting its level of temperature sensitivity. In addition, the P3 RNA of the ts+ virus migrated more slowly in polyacrylamide gel than the P3 RNA of its A/Alaska/77-ts-1A2 parent. We failed to isolate ts P1 segregants from the ts+ isolate, indicating that the P1 ts mutation had reverted or undergone intragenic suppression. The ability of ts mutants to escape from their ts phenotype by suppression and other mutations may limit their usefulness in immunoprophylaxis since attenuation of ts mutants of influenza virus appears to be a function of the ts phenotype. Additionally, suppressor mutations provide new opportunities for studying the nature of protein-protein interactions.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Tolpin, Mark D" sort="Tolpin, Mark D" uniqKey="Tolpin M" first="Mark D." last="Tolpin">Mark D. Tolpin</name>
</noRegion>
<name sortKey="Chanock, Robert M" sort="Chanock, Robert M" uniqKey="Chanock R" first="Robert M." last="Chanock">Robert M. Chanock</name>
<name sortKey="Kim, Hyun Wha" sort="Kim, Hyun Wha" uniqKey="Kim H" first="Hyun Wha" last="Kim">Hyun Wha Kim</name>
<name sortKey="Massicot, Judith G" sort="Massicot, Judith G" uniqKey="Massicot J" first="Judith G." last="Massicot">Judith G. Massicot</name>
<name sortKey="Mullinix, Mary G" sort="Mullinix, Mary G" uniqKey="Mullinix M" first="Mary G." last="Mullinix">Mary G. Mullinix</name>
<name sortKey="Murphy, Brian R" sort="Murphy, Brian R" uniqKey="Murphy B" first="Brian R." last="Murphy">Brian R. Murphy</name>
<name sortKey="Parrott, Robert H" sort="Parrott, Robert H" uniqKey="Parrott R" first="Robert H." last="Parrott">Robert H. Parrott</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002731 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002731 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F8B30400DE92CE68D6CB321902227B108E7C2901
   |texte=   Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021